Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

CAT's anti-TGF-beta2 antibody approved for phase I/IIa trials

Aug. 26, 1997

FDA approves expansion of Sunrise Technologies' hyperopia study

Aug. 26, 1997

InSite Vision initiates phase II study of ISV-120

Aug. 21, 1997

Generic levobunolol approved in Canada

Aug. 13, 1997

FDA releases Staar's implantable contact lens for phase II trials

Aug. 11, 1997

Boston Life Sciences begins preclinical program for ophthalmic indications of antiangiogenic product

July 18, 1997

New insights into glaucoma and implications for drug therapy

July 15, 1997

Prostaglandins in early development at Allergan for glaucoma

July 4, 1997

BioSpecifics Technologies and Bausch & Lomb collaborate on glaucoma studies

June 27, 1997

Genistein prevents ischemic retinal degeneration in rats

June 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...